Log on / register
Feedback | Support | My details
Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value.
van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ
Arthritis Res 2002, 4:87-93
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.
Arita K, Shimizu T, Hashimoto H, Hidaka Y, Yamada M, Sato M
Proc Natl Acad Sci U S A 2006 Apr 4, 103:5291-6
[PubMed Central] [PubMed] [Related articles]

2.
Cytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis.
Aidinis V, Carninci P, Armaka M, Witke W, Harokopos V, Pavelka N, Koczan D, Argyropoulos C, Thwin MM, Möller S, Waki K, Kazunori W, Gopalakrishnakone P, Ricciardi-Castagnoli P, Thiesen HJ, Hayashizaki Y, Kollias G
PLoS Genet 2005 Oct, 1:e48
[PubMed Central] [PubMed] [Related articles]

3.
The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis.
Moscarello MA, Mastronardi FG, Wood DD
Neurochem Res 2007 Feb, 32:251-6
[PubMed Central] [PubMed] [Related articles]

4.
Diagnostic value and clinical significance of anti-CCP in patients with advanced rheumatoid arthritis.
Samanci N, Ozdem S, Akbas H, Mutlu D, Gultekin M, Arman M, Donmez L
J Natl Med Assoc 2005 Aug, 97:1120-6
[PubMed Central] [PubMed] [Related articles]

5.
Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis.
Harris ML, Darrah E, Lam GK, Bartlett SJ, Giles JT, Grant AV, Gao P, Scott WW, El-Gabalawy H, Casciola-Rosen L, Barnes KC, Bathon JM, Rosen A
Arthritis Rheum 2008 Jul, 58:1958-67
[PubMed Central] [PubMed] [Related articles]

6.
Clinical utility of the anti-CCP assay in patients with rheumatic diseases.
Lee DM, Schur PH
Ann Rheum Dis 2003 Sep, 62:870-4
[PubMed Central] [PubMed] [Related articles]

7.
Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.
Vossenaar ER, Radstake TR, van der Heijden A, van Mansum MA, Dieteren C, de Rooij DJ, Barrera P, Zendman AJ, van Venrooij WJ
Ann Rheum Dis 2004 Apr, 63:373-81
[PubMed Central] [PubMed] [Related articles]

8.
Unlocking the "PAD" lock on rheumatoid arthritis.
Utz PJ, Genovese MC, Robinson WH
Ann Rheum Dis 2004 Apr, 63:330-2
[PubMed Central] [PubMed] [Related articles]

9.
Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?
Koivula MK, Aman S, Karjalainen A, Hakala M, Risteli J
Ann Rheum Dis 2005 Oct, 64:1443-50
[PubMed Central] [PubMed] [Related articles]

10.
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression.
Rönnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, van Vollenhoven RF
Ann Rheum Dis 2005 Dec, 64:1744-9
[PubMed Central] [PubMed] [Related articles]

11.
Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review.
Avouac J, Gossec L, Dougados M
Ann Rheum Dis 2006 Jul, 65:845-51
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 11 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.